HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity
FRIDAY, July 15, 2022 -- Non-Hispanic White men are disproportionately affected by late-stage human papillomavirus (HPV)-related oropharyngeal cancer (OPC), but cancer-specific mortality (CSM) is elevated among Hispanic and non-Hispanic Black men,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 15, 2022 Category: Pharmaceuticals Source Type: news
2015 to 2020 Saw Increase in HPV Vaccination Rates Among Teens
FRIDAY, June 24, 2022 -- Human papillomavirus (HPV) vaccination coverage increased among adolescents from 2015 to 2020, with a larger increase seen among boys, according to a study published online June 22 in Pediatrics.
Peng-jun Lu, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 24, 2022 Category: Pharmaceuticals Source Type: news
HPV Vaccination Rates Continue to Rise
(MedPage Today) -- Overall rates of human papillomavirus (HPV) vaccination among adolescents increased by nearly 20% over a 5-year period, according to survey data.
Among teens ages 13 to 17, overall HPV vaccine coverage increased from 56.1% in... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - June 22, 2022 Category: Infectious Diseases Source Type: news
Reducing sexually transmitted infections [NG221], NICE (published 15th June 2022)
Guideline covers interventions to prevent sexually transmitted infections (STIs) in people from 16yrs age. It aims to reduce the transmission of all STIs, including HIV,& includes ways to help increase uptake of STI testing& vaccines for human papillomavirus& hepatitis A&B. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 16, 2022 Category: Consumer Health News Source Type: news
Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options
Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by infection with Human Papillomavirus (HPV).1Nearly nine out of 10 women who die from cervical cancer live in low- and middle-income countries.2For patients living in areas with limited healthcare resources, increasing access to screening and decreasing barriers to sample collection are keys to ultimately preventing this disease.Roche ’s HPV self sampling solution expands access to HPV screening options by enabling patients to privately collect their sample while at a healthcare...
Source: Roche Investor Update - June 16, 2022 Category: Pharmaceuticals Source Type: news
Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options
Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by infection with Human Papillomavirus (HPV).1Nearly nine out of 10 women who die from cervical cancer live in low- and middle-income countries.2For patients living in areas with limited healthcare resources, increasing access to screening and decreasing barriers to sample collection are keys to ultimately preventing this disease.Roche ’s HPV self sampling solution expands access to HPV screening options by enabling patients to privately collect their sample while at a healthcare...
Source: Roche Media News - June 16, 2022 Category: Pharmaceuticals Source Type: news
5-Year Interval for Cervical Cancer Screening Safe in HPV-Negative Women
(MedPage Today) -- Women ages 24 to 49 who initially test negative for the human papillomavirus (HPV) can be safely screened for cervical cancer at 5-year intervals, according to results from a U.K. study.
Using data from the first and second... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 3, 2022 Category: Hematology Source Type: news
Alercell Starts to Distribute Human Papilloma Virus (HPV) DNA Test
BOZEMAN, Mont., May 25, 2022 -- (Healthcare Sales & Marketing Network) -- Alercell, announced today that it will begin distributing an HPV DNA based test kit: "Meltpro HPV genotype test" the test is based on DNA sequencing analysis.
The Meltp... Diagnostics, Product Launch Alercell, Human Papilloma Virus, HPV (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 25, 2022 Category: Pharmaceuticals Source Type: news
Increasing Impact of HPV Vaccination Seen in the United States
TUESDAY, May 17, 2022 -- The impact of human papillomavirus (HPV) vaccination is increasing in the United States, with evidence of herd protection, according to a study published online May 17 in the Annals of Internal Medicine.
Hannah G.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2022 Category: Pharmaceuticals Source Type: news
Benefits of HPV Immunization Spilling Over to the Unvaxxed
(MedPage Today) -- Human papillomavirus (HPV) vaccination was associated with a 90% reduction in four types of cervical HPV infections in sexually active girls and young women, a cross-sectional study found.
For unvaccinated females in the study... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 17, 2022 Category: Hematology Source Type: news
SII seeks govt's nod to manufacture, stockpile qHPV vaccine against cervical cancer
The Serum Institute of India has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer after the completion of the phase 2/3 clinical trials to ensure its early availability in the country, official sources said (Source: The Economic Times)
Source: The Economic Times - May 15, 2022 Category: Consumer Health News Source Type: news
F.D.A. Authorizes Underwear to Protect Against S.T.I.s During Oral Sex
It ’s the first time underwear has been authorized for this purpose, and it provides a new choice for protection where the few options have been unpopular. (Source: NYT Health)
Source: NYT Health - May 12, 2022 Category: Consumer Health News Authors: Pam Belluck Tags: Sex Head and Neck Cancer Lingerie and Underwear Sexually Transmitted Diseases Women and Girls Mouth Vagina Human Papillomavirus (HPV) Food and Drug Administration your-feed-science your-feed-healthcare Source Type: news
Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world ’s population has no or limited access to diagnosticsThis situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIVNew partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treatedBasel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Globa...
Source: Roche Media News - May 12, 2022 Category: Pharmaceuticals Source Type: news
Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world ’s population has no or limited access to diagnosticsThis situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIVNew partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treatedBasel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Globa...
Source: Roche Investor Update - May 12, 2022 Category: Pharmaceuticals Source Type: news
Self-Collected Menstrual Blood to Detect HPV?
(MedPage Today) -- Self-collected menstrual blood samples offered "highly concordant" results with clinician-collected sampling in women who were positive for human papillomavirus (HPV), a researcher reported.
In a small study of about 100 women... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 9, 2022 Category: Hematology Source Type: news
